Septerna, Inc.
Key Metrics
- Previous Close
- $40.02
- 52-Week Range
- $22.78 – $53.34
- Market Cap
- $1.88B
- P/E (TTM)
- —
- EPS (TTM)
- -1.30
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 4.37
- PEG Ratio
- —
- Return on Equity
- -14.45%
- Return on Assets
- -7.48%
- Gross Margin
- 100.00%
- Operating Margin
- -76.23%
- Profit Margin
- -61.29%
- Current Ratio
- 4.84
- Debt/Equity
- 0.05
- Total Debt
- $21.99M
- Free Cash Flow
- $-7.81M
- Revenue Growth
- -12.20%
- Earnings Growth
- —
- Enterprise Value
- $1.42B
Market Snapshot
About
Septerna, Inc. is a clinical-stage biotechnology company focused on discovering and developing oral small molecule drugs for G protein-coupled receptor targets. The company utilizes a proprietary Native Complex Platform to unlock challenging GPCR targets across various therapeutic areas. Septerna aims to create transformative medicines for patients with significant unmet medical needs.